Feline infectious peritonitis
GPTKB entity
Statements (57)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:healthcare_organization
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Feline_Immunodeficiency_Virus
|
gptkbp:affects |
cats
|
gptkbp:associated_with |
FIP virus
cattery environments |
gptkbp:caused_by |
Feline coronavirus
|
gptkbp:clinical_trial |
gptkb:fandom
jaundice diarrhea respiratory distress neurological signs |
gptkbp:end_of_life |
high
|
gptkbp:first_described_by |
1960s
|
https://www.w3.org/2000/01/rdf-schema#label |
Feline infectious peritonitis
|
gptkbp:incubation_period |
2 to 14 days
|
gptkbp:is_often_used_in |
young cats
immunocompromised cats |
gptkbp:is_protected_by |
no vaccine available
|
gptkbp:research |
ongoing
|
gptkbp:research_areas |
therapeutic agents
vaccine development diagnostic methods |
gptkbp:research_focus |
immune response
pathogenesis |
gptkbp:risk_factor |
stress
age genetic predisposition multi-cat households |
gptkbp:social_responsibility |
gptkb:hospital
seasonal outbreaks global distribution serology PCR test higher incidence in purebred cats increased risk in overcrowded conditions prevalent in shelters |
gptkbp:symptoms |
weight loss
fever dehydration lethargy loss of appetite fluid accumulation abdominal swelling behavior changes |
gptkbp:transmission |
not contagious between cats
|
gptkbp:treatment |
gptkb:drug
variable antibiotics nutritional support supportive care corticosteroids poor prognosis immunosuppressive drugs some cases improve |
gptkbp:type |
dry form
wet form |